Inhibition of complement alternative pathway by ACH-4471, the first clinical investigational orally-administered inhibitor of complement factor D. (September 2017) - Huang, Mingjun; Yang, Wengang; Podos, Steven D.; Yang, Guangwei; Zhao, Yongsen; Thanassi, Jane A.; Patel, Dharaben; Fabrycki, Joanne; Luu, Amanda; Galvan, Manuel; Yuan, Xuan; Brodsky, Robert; et al.